Kurs
-5,41%
Kurs
-5,41%
Open
0,90
High
1,06
Low
0,88
Close
1,05
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
| Est. tid* | ||
| 2025-08-29 | 12:20 | Kvartalsrapport 2025-Q2 |
| 2025-07-03 | N/A | Extra Bolagsstämma 2025 |
| 2025-05-30 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2025-03-18 | - | Bokslutskommuniké 2024 |
| 2025-01-14 | - | Split OBSRV 15:1 |
| 2024-08-26 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-27 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2024-05-24 | - | Årsstämma |
| 2024-03-13 | - | Bokslutskommuniké 2023 |
| 2023-11-22 | - | Extra Bolagsstämma 2023 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-30 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2023-05-26 | - | Årsstämma |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-03 | - | 15-10 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-03 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2022-06-03 | - | Årsstämma |
| 2022-03-29 | - | Bokslutskommuniké 2021 |
| 2022-02-04 | - | Extra Bolagsstämma 2022 |
| 2021-11-03 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-25 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2021-05-21 | - | Årsstämma |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-23 | - | Bokslutskommuniké 2020 |
| 2020-11-03 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-18 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2020-06-30 | - | Årsstämma |
| 2020-06-16 | - | Extra Bolagsstämma 2020 |
| 2020-05-12 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-25 | - | Bokslutskommuniké 2019 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2025-06-12 07:55:13
Issuer name: Observe Medical ASA
Ex. date: 12 June 2025
Type of corporate action: Subsequent offering/repair issue
Other information: Reference is made to the stock exchange announcement
published by Observe Medical ASA on 11 June 2025 with key information relating
to the subsequent offering.
This information is published in accordance with the requirements of the
Continuing Obligations.